Page 1090 - Veterinary Toxicology, Basic and Clinical Principles, 3rd Edition
P. 1090

1022 SECTION | XV Mycotoxins




  VetBooks.ir  neuroinflammation and neurotoxicity (Belmadani et al.,  reduction of antioxidant defense appears to be involved in
                                                                OTA toxicity and carcinogenicity. Interestingly, Taniai
             1998; Bruinink et al., 1998; Von Tobel et al., 2014). This
                                                                et al. (2014) reported that OTA induces karyomegaly and
             mycotoxin has multiple mechanisms of action, including
             oxidative stress, bioenergetic compromise, inhibition of  cell cycle aberrations in renal tubular cells without induc-
             protein synthesis, production of DNA single-stranded  ing oxidative stress.
             breaks, and formation of OTA-DNA adducts (Sava et al.,
             2006; Gonza ´lez-Arias et al., 2014). Sava et al. (2006)  TOXICITY
             reported that administration of OTA in mice, at a single
             dose (3.5 mg/kg) that is approximately 10% of the  The toxic effects of OTA have been studied extensively
             reported LD 50 , caused widespread oxidative injury in six  in a number of domestic, companion and experimental
             discrete brain regions.                            animals. All evidence suggests that OTA continues to be
                                                                a huge problem to animal health worldwide (O’Brien and
             Immunotoxicity                                     Dietrich, 2005; Gupta et al., 2017). Overall toxicity of
                                                                OTA is greatly influenced by species, sex and route of
             There is ample evidence from studies conducted in  administration. Based on acute toxicity data, dogs, pigs,
             several animal species that under certain conditions of  and chickens are the most sensitive species and rats and
             treatment, OTA can produce defects in the structure and/  mice the least sensitive. Oral LD 50 values (expressed as
             or function of elements comprising the immune system  mg/kg body weight) of OTA are reported to be 46 58 in
             (Pohland et al., 1992; Khatoon et al., 2013; Marin and  mouse, 20 30 in rat, 3.9 in neonate rat, 0.2 in dog, 1 in
             Taranu, 2014; Kupski et al., 2016). The size of the mouse  pig, and 3.3 in chicken (Harwig et al., 1983). LD 50 values
             thymus was reduced to 33% of that of controls after four  via i.p. route are reported to be 22 40 in mouse and
             i.p. injections of OTA at 20 mg/kg body weight on alter-  20 30 in rat; and with i.v. route, 26 34 in mouse and
             nate days, a dose that caused minimal nephrotoxicity.  13 mg/kg in rat. OTA causes renal toxicity, nephropathy,
             Bone marrow depression was dose related, and changes  neurotoxicity, immunotoxicity, carcinogenicity and devel-
             included decreased marrow cellularity, a reduction in  opmental/reproductive toxicity in several animal species
             bone marrow macrophage-granulocyte progenitors, a  (reviewed in Gupta et al., 2017).
             decreased number of hematopoietic stem cells, a signifi-  The acute LD 50 (expressed as mg/kg body weight) of
             cant decrease in erythropoiesis and increased phagocyto-  citrinin is reported to be 50 (oral) and 67 (s.c. or i.p.) in
             sis by macrophages (Boorman et al., 1984). The effects of  rat, 35 58 in mouse and 19 (i.p. or i.v.) in rabbit. Citrinin
             OTA on the bone marrow and lymphatic cell population  toxicity, especially in terms of nephropathy, has been
             may reflect the sensitivity of these cells to the inhibition  reported in various animal species, including rats, ham-
             of protein synthesis. These effects on the structural com-  sters, dogs and poultry. Citrinin causes kidney damage
             ponents of the immune system indicated that OTA    and mild liver damage in the form of fatty infiltration.
             adversely affects immune function.                 Other toxic effects include vasodilatation, constriction of
                In chickens fed diets containing OTA at a concentra-  the bronchi and increased muscular tone.
             tion of 2 4 mg/kg for 20 days, the lymphoid cell popula-  All animals studied so far have been found susceptible
             tion of immune organs was decreased, and IgA and IgM  to orally administered OTA with a varying degree of
             in lymphoid tissues and serum were decreased (Dwivedi  response. It is important to mention that at higher doses,
             and Burns, 1984a,b). Complement activity was slightly  OTA causes alterations in kidneys and also in other
             affected in birds fed diets containing 2 mg/kg for 5 6  organs and tissue, but renal lesions can be found at an
             weeks (Campbell et al., 1983). Immune suppression was  exposure level that is identical to those occurring environ-
             observed in chickens fed diets containing OTA at 0.05 or  mentally. OTB is rarely found as a natural contaminant
             2 mg/kg for 21 days. Treated animals showed reduced  and is much less toxic than OTA. The other ochratoxins
             total serum protein, lymphocyte counts and weights of the  have never been encountered in natural products.
             thymus, bursa of fabricus and spleen (Singh et al., 1990).  Weanling Fischer 344/N rats of both sexes receiving
                                                                OTA by gavage in maize oil at a dose of 0.06, 0.12, 0.25,
                                                                0.5 or 1 mg/kg body weight/day for 5 days/week for 91
             Carcinogenicity
                                                                days, showed growth retardation and a reduced relative
             The exact mechanism by which OTA induces nephrocar-  kidney weight in males at the two higher doses.
             cinogenicity is yet to be established, although both geno-  Karyomegaly of dose-related severity was observed in the
             toxic and nongenotoxic modes of action seem to be  proximal tubules at all doses. Milder renal changes con-
             involved (Pfohl-Leszkowicz and Manderville, 2007;  sisting of tubular atrophy were seen at a dose of 1, 4, or
             Marin-Kuan et al., 2008; Golli-Bennour et al., 2010;  16 mg/kg body weight/day on 5 days/week for a total of
             Stoev, 2010a, b). Cavin et al. (2007) suggested that the  12 doses over 16 days. Rats receiving the highest dose
   1085   1086   1087   1088   1089   1090   1091   1092   1093   1094   1095